Genetic determinants of breast cancer risk: A review of current literature and issues pertaining to clinical application

Breast Journal

Volumn 18, Issue 5, 2012, Pages 436-442

  Njiaju, Uchenna O ^a   Olopade, Olufunmilayo I ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

breast cancer; genetic risk; risk reduction

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER REGRESSION; CANCER RISK; CLINICAL FEATURE; FAMILIAL CANCER; FAMILY HISTORY; GENETIC ASSOCIATION; HUMAN;

BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MUTATION; POLYMORPHISM, GENETIC;

EID: 84866083952     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2012.01274.x     Document Type: Article

References (46)

1. American Cancer Society (ACS) A, Georgia, 2009. Cancer Facts and Figures-2009. 2009.
2. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81: 1879-86.
3. Claus EB, Risch N, Thompson WD,. The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res Treat 1993; 28: 115-20.
4. Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684-9.
5. Szabo CI, King MC,. Inherited breast and ovarian cancer. Hum Mol Genet 1995; 4: 1811-7. Spec No:1811-1817.
6. Foulkes WD,. Inherited susceptibility to common cancers. N Engl J Med 2008; 359: 2143-53.
7. De Grève J, Sermijn E, De Brakeleer S, Ren Z, Teugels E,. Hereditary breast cancer: from bench to bedside. Curr Opin Oncol 2008; 20: 605-13.
8. Easton DF,. How many more breast cancer susceptibility genes are there? Breast Cancer Res 1999; 1: 14-7.
9. Thompson D, Easton D,. The genetic epidemiology of breast cancer genes. J Mamm Gland Biol Neoplasia 2004; 9: 221-36.
10. Garcia-Closas M, Chanock S,. Genetic susceptibility loci for breast cancer by estrogen receptor status. Clin Cancer Res 2008; 14: 8000-9.
11. Pharoah PD, Antoniou A, Easton D, Ponder BA,. Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 2008; 358: 2796-803.
12. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA,. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002; 31: 33-6.
13. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004; 431: 931-45.
14. Cox A, Dunning A, Garcia-Closas M, et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 2007; 39: 352-8.
15. Garcia-Closas M, Malats N, Silverman D, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005; 366: 649-59.
16. Easton DF, Pooley KA, Dunning AM, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007; 447: 1087-93.
17. Hunter DJ, Kraft P, Jacobs KB, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007; 39: 870-4.
18. Garcia-Closas M, Hall P, Nevanlinna H, et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 2008; 4: e1000054.
19. Hengartner MO,. The biochemistry of apoptosis. Nature 2000; 407: 770-6.
20. Baer HJ, Brawarsky P, Murray MF, Haas JS,. Familial risk of cancer and knowledge and use of genetic testing. J Gen Intern Med 2010; 25: 717-24.
21. Vig HS, Armstrong J, Egleston BL, et al. Cancer genetic risk assessment and referral patterns in primary care. Genet Test Mol Biomarkers 2009; 13: 735-41.
22. Bradbury AR, Dignam JJ, Ibe CN, et al. How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults. J Clin Oncol 2007; 25: 3705-11.
23. Mackenzie A, Patrick-Miller L, Bradbury AR,. Controversies in communication of genetic risk for hereditary breast cancer. Breast J. 2009; 15 (Suppl. 1): S25-32.
24. Bradbury AR, Patrick-Miller L, Pawlowski K, et al. Should genetic testing for BRCA1/2 be permitted for minors? Opinions of BRCA mutation carriers and their adult offspring. Am J Med Genet C Semin Med Genet. 2008; 148C: 70-7.
25. Bradbury AR, Ibe CN, Dignam JJ, et al. Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers. Genet Med 2008; 10: 161-6.
26. Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K,. American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility. J Clin Oncol 2010; 28: 893-901.
27. American Society of Clinical Oncology. American Society of Clinical Oncology Policy Statement Update: Genetic testing for cancer susceptibility. J Clin Oncol 2003; 21: 2397-406.
28. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57: 75-89.
29. Berry DA, Iversen ES Jr, Gudbjartsson DF, et al. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 2002; 20: 2701-12.
30. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE,. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994; 343: 692-5.
31. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401-8.
32. Andrieu N, Goldgar DE, Easton DF, et al. Pregnancies, Breast-Feeding and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst 2006; 98: 535-44.
33. Hughes DJ,. Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Fam Cancer 2008; 7: 233-44.
34. Jernström H, Lubinsky J, Lynch HT, et al. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2004; 96: 1094-8.
35. Milne RL, Osorio A, Ramn y Cajal T, et al. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2010; 119: 221-32.
36. Narod SA, Dubé MP, Klijn J, et al. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2002; 94: 1773-9.
37. Birch JM, Alston RD, McNally RJ, et al. Relative frequency and morphology of cancers in carriers of germline mutations. Oncogene 2001; 20: 4621-8.
38. Ries LAG, Melbert D, Krapcho M, et al. SEER cancer statistics review, 1975-2005. 2008.
39. Giardello FM, Brensinger JD, Tersmette AC,. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000; 119: 1447-53.
40. Hearle N, Schumacher V, Menko FH, et al. Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 2006; 12: 3209-15.
41. Beeghly-Fadiel A, Lu W, Gao Y, et al. E-cadherin polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study. Breast Cancer Res Treat 2010; 121: 445-52. Oct 16 (Epub ahead of print).
42. Renwick A, Thompson D, Seal S, et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 2006; 38: 873-5.
43. Meijers-Heijboer H, van den Ouweland A, Klijn J, et al. Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations. The CHEK2-Breast Cancer Consortium. Nat Genet 2002; 31: 55-9.
44. Freisinger F, Domcheck SM,. Clinical implications of low-penetrance breast cancer susceptibility alleles. Curr Oncol Rep 2009; 11: 8-14.
45. Seal S, Thompson D, Renwick A, et al. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 2006; 38: 1239-41.
46. Cao AY, Yu KD, Yin WJ, et al. Five common single nucleotide polymorphisms in the PALB2 gene and susceptibility to breast cancer in eastern Chinese population. Breast Cancer Res Treat 2010; 123: 133-8.